Emerging Drug Delivery Platforms Shaping the Future of Retinal Care
The future of back of the eye disorder treatment depends not only on drug innovation but also on how therapies are delivered. Emerging delivery platforms are designed to maximize efficacy while minimizing patient burden.
Smart implants capable of responding to disease activity are under development. These systems adjust drug release based on retinal conditions, offering adaptive therapy.
Micro- and nano-scale delivery devices enable precise targeting, reducing waste and enhancing therapeutic impact. These platforms support both existing and next-generation drugs.
As delivery technologies continue to advance, they will play a defining role in improving outcomes for patients with back of the eye disorders.
1 View